Article

Focus on 0.15% version: Allergan discontinues brimonidine 0.2% solution

Irvine, CA-Allergan plans to discontinue U.S. distribution of its 0.2% brimonidine tartrate ophthalmic solution (Alphagan) because of what it calls the overwhelming popularity of its 0.15% counterpart, Alphagan P.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.